Increased Transforming Growth Factor- Levels Associated With Cardiac Adverse Events in Hypertrophic Cardiomyopathy
CLINICAL CARDIOLOGY, cilt.38, sa.6, ss.371-377, 2015 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 38 Sayı: 6
- Basım Tarihi: 2015
- Doi Numarası: 10.1002/clc.22404
- Dergi Adı: CLINICAL CARDIOLOGY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.371-377
- Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
- İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır
Özet
BackgroundHypertrophic cardiomyopathy (HCM) is a common genetic heart disease characterized by ventricular hypertrophy, myocardial fibrosis, and impaired ventricular relaxation. The exact mechanisms by which fibrosis is caused remain unknown.